AnodyneWiki

Dihydrocodeine

Dihydrocodeine
Dihydrocodeine
Salts
[]
Dihydrocodeine bitartrate
Dihydrocodeine bitartrate
Dihydrocodeine phosphate
Dihydrocodeine phosphate
Dihydrocodeine hydrochloride
Dihydrocodeine hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass301.40 g/mol [1]
Melting point112.5 °C [1]
Predicted LogP2.2 [1]
Structural Identifiers
[]
Molecular formulaC18H23NO3
IUPAC name(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol
SMILESCN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](CC4)O
InChIInChI=1S/C18H23NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-13,17,20H,4-5,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1
InChIKeyRBOXVHNMENFORY-DNJOTXNNSA-N
CAS number125-28-0
UNIIN9I9HDB855
PubChem CID5284543
Pharmacokinetics[]
Elimination half-life4 hours
Routes of administrationOral, subcutaneous, intramuscular, rectal, sublingual, buccal
Dependence liabilityHigh
Addiction liabilityHigh
Dosing[]
Oral
[]
Threshold8
Light≤ 8
Common8 - 30
Strong30 - 60
Heavy60 - 105
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki)
We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly.

Dihydrocodeine (also known as Rapacodin, Novicondin, Codhydrine, Dehacodin, Hydrocodeine, 8,14-Dihydroneopine, Dihidrocodeina, Dihydroneopine, Cohydrin or α-Hydrocodol) is a opioid substance of the 2-benzylpiperidine and morphinan class.

Chemistry

Salts []

Dihydrocodeine is typically found in the form of its bitartrate, phosphate and hydrochloride salts.

 []

Dihydrocodeine is a single defined stereoisomer.

Dihydrocodeine matches Lipinski's rule of five.

There are currently 2 reagent-interactions on

ReagentColor changeDescription
Marquisviolet
Mandelingrey / > green

Pharmacology

Mechanism of action []

Dihydrocodeine is metabolized to dihydromorphine -- a highly active metabolite with a high affinity for mu opioid receptors. [3] [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / inhibition / induction34
shared target20 (2 contraindicated)
metabolism2

Medical side effects []

44 side effects listed on drug labels in (dihydrocodeine).

  • Abdominal pain
  • Gastrointestinal pain
  • Constipation
  • Nausea
  • Vomiting
  • Dry mouth
  • Somnolence
  • Angioedema
  • Confusional state
  • Feeling abnormal
  • Diarrhoea
  • Dizziness
  • Dyspnoea
  • Dermatitis
  • Rash
  • Hallucination
  • Headache
  • Hyperhidrosis
  • Hypotension
  • Ileus paralytic
  • Paraesthesia
  • Pruritus
  • Convulsion
  • Withdrawal syndrome
  • Urticaria
  • Vertigo
  • Urinary retention
  • Mood swings
  • Affect lability
  • Biliary colic
  • Dysphoria
  • Respiratory depression
  • Pulmonary function test decreased
  • Hepatic enzyme increased
  • Mental disorder
  • Gastrointestinal disorder
  • Immune system disorder
  • Mediastinal disorder
  • Nervous system disorder
  • Urethral disorder
  • Urinary tract disorder
  • Angiopathy
  • Skin disorder
  • Hepatobiliary disease

Indications

  • Chronic pain
  • Neoplasm malignant
  • Pain
  • Postoperative pain

Subjective effects []

bonzi / Dihydrocodeine []
Routes:
  • Oral (120mg)
nervewing / Dihydrocodeine []

 []

  • Australia: Dihydrocodeine is a Schedule 3.
  • Brazil: Dihydrocodeine is a A2.[3]
  • Canada: Dihydrocodeine is a Schedule I.
  • Germany: Dihydrocodeine is Prescription only/Anlage III.
  • New Zealand: Dihydrocodeine is a Class C2.[4]
  • United Kingdom: Dihydrocodeine is a Class B under the "Misuse of Drugs Act 1971".
  • United States: Dihydrocodeine is a Schedule II (Schedule III in drug combination) under the "Controlled Substances Act".

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5284543, Dihydrocodeine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5284543
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Dihydrocodeine. UNII: N9I9HDB855. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/N9I9HDB855
  3. RDC Nº 784 – Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
  4. Dihydrocodeine Datasheet. Medsafe. https://www.medsafe.govt.nz/profs/datasheet/d/DHCContinustab.pdf

Data sources []

SourceStatusUpdated (UTC)
dosingok2026-11-20 05:19:44
drugsprook2026-11-20 05:19:40
erowidmissing (no Erowid substance of that name)2026-11-20 05:19:40
gsrsok2026-11-20 05:19:43
hmdbmissing (no HMDB id)2026-11-20 05:19:40
keggok2026-11-20 05:19:42
pubchemok2026-11-20 05:19:39
redditmissing (no r/tripreports posts mention it)2026-11-20 05:19:40
siderok2026-11-20 05:19:40
structureok2026-11-20 05:19:40
wikipediaok2026-11-20 05:19:40